(19)
(11) EP 2 968 823 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
16.02.2022 Bulletin 2022/07

(45) Mention of the grant of the patent:
12.01.2022 Bulletin 2022/02

(21) Application number: 14765748.0

(22) Date of filing: 14.03.2014
(51) International Patent Classification (IPC): 
A61M 16/08(2006.01)
A61M 16/01(2006.01)
 A61M 16/06(2006.01)
A61M 16/16(2006.01)
(52) Cooperative Patent Classification (CPC):
A61M 16/16; A61M 16/0808; A61M 16/0875; A61M 2205/3368; A61M 2205/3633; A61M 2205/50; A61M 16/0833; A61M 16/1095; A61M 16/161
(86) International application number:
PCT/NZ2014/000039
(87) International publication number:
WO 2014/142680 (18.09.2014 Gazette 2014/38)

(54)

COMPONENTS FOR MEDICAL CIRCUITS

BESTANDTEILE FÜR MEDIZINISCHE SCHALTKREISE

ÉLÉMENTS POUR CIRCUITS MÉDICAUX

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 15.03.2013 US 201361790424 P
15.03.2013 US 201361789754 P
08.01.2014 US 201461925099 P

(43) Date of publication of application:
20.01.2016 Bulletin 2016/03

(60) Divisional application:
21214032.1

(73) Proprietor: Fisher & Paykel Healthcare Limited
East Tamaki, 2013 Manukau (NZ)

(72) Inventors:
  • MILNE, Robert Andrew David
    Auckland 2013 (NZ)
  • GIERKE, Timothy Dee
    Auckland 2014 (NZ)

(74) Representative: Treeby, Philip David William et al
Maucher Jenkins Seventh Floor Offices Artillery House 11-19 Artillery Row
London SW1P 1RT
London SW1P 1RT (GB)


(56) References cited: : 
EP-B1- 0 535 379
WO-A1-2004/105847
US-A- 6 078 730
US-A1- 2004 099 268
 EP-B1- 0 535 379
WO-A1-2011/077250
US-A1- 2004 099 268
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).